We are live on
!
Find out more
SELLAS Life Sciences
33 hedge funds and large institutions have $6.76M invested in SELLAS Life Sciences in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
5,392% more call options, than puts
Call options by funds: $5.27M | Put options by funds: $96K
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
39% more capital invested
Capital invested by funds: $4.86M → $6.76M (+$1.9M)
10% more funds holding
Funds holding: 30 → 33 (+3)
1.34% more ownership
Funds ownership: 7.06% → 8.41% (+1.3%)
Holders
33
Holders Change
+3
Holders Change %
+10%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
11
Reduced
5
Closed
4
Calls
$5.27M
Puts
$96K
Net Calls
+$5.18M
Net Calls Change
-$2.2M
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$970K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$619K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$108K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$76.7K |
| 5 |
Renaissance Technologies
New York
|
+$73.9K |
Top Sellers
| 1 |
EH
Equitable Holdings
New York
|
-$242K |
| 2 |
Millennium Management
New York
|
-$127K |
| 3 |
Jane Street
New York
|
-$34.2K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$18K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.1K |
